Trials / Terminated
TerminatedNCT00508911
A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills
An Open-label, Repeat-dose, Single-sequence Study to Investigate the Effects of Once-daily Repeat Oral Administration of GW876008 125mg on the Pharmacokinetics of the Combined Oral Contraceptive in Female Volunteers
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study will be conducted in healthy female volunteers to investigate the effect of GW876008 on the pharmacokinetics of oral contraceptive pills.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GW876008 | GW876008 tablets will be available as white to off-white coated tablets. Each subject will receive a single oral dose of GW876008, daily for up to 35 days in Session 2. GW876008 will be administered in the morning with a light breakfast. |
| DRUG | COC | COC containing ethinylestradiol 30 microgram and levonorgestrel 150 microgram will be administered in the morning with a light breakfast. |
Timeline
- Start date
- 2007-06-08
- Primary completion
- 2007-10-22
- Completion
- 2007-10-22
- First posted
- 2007-07-30
- Last updated
- 2017-08-04
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00508911. Inclusion in this directory is not an endorsement.